Trial Profile
Ipidacrine in patients with post-stroke cognitive impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2014
Price :
$35
*
At a glance
- Drugs Ipidacrine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 28 Apr 2014 New trial record